Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
07:00am, Thursday, 29'th Feb 2024
GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial r
New CEO Appointment A Clear Positive For Emergent BioSolutions
11:31am, Tuesday, 27'th Feb 2024
New CEO Appointment A Clear Positive For Emergent BioSolutions
Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?
03:24pm, Wednesday, 21'st Feb 2024
In today's market, one of the biggest winners generating outsized interest is Emergent Biosolutions (NYSE: EBS ). This mid-cap biotech company remains a unique turnaround story for investors, and many
Contrarian Calls: 7 Analyst ‘Sell' Ratings That Should Be ‘Buys'
02:01pm, Wednesday, 31'st Jan 2024
While it's usually a solid principle to bet alongside Wall Street's top experts, sometimes, they don't get it right, which brings us to contrarian analyst picks. You know how I've been supporting my a
Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine
03:47pm, Friday, 12'th Jan 2024
Emergent (EBS) signs a deal with the U.S. Department of Defense to supply its anthrax vaccine initially for a five-year period, with an option to extend it for another five years.
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
07:30am, Tuesday, 09'th Jan 2024
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending pr
Shares of Emergent BioSolutions Inc. EBS slumped 2.8% in afternoon trading Tuesday, after surging more than 11% over the past two sessions, including Friday's 8.3% rally. The rally to end last week ca
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
01:34pm, Wednesday, 29'th Nov 2023
The BARDA is exercising an option to procure additional doses of Emergent BioSolutions' (EBS) recently approved anthrax vaccine. Deliveries will likely be completed by the end of first-quarter 2024.
Emergent BioSolutions Inc. (EBS) Q3 2023 Earnings Call Transcript
11:06pm, Wednesday, 08'th Nov 2023
Emergent BioSolutions Inc. (NYSE:EBS ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Haywood Miller - Interim Chief Executive Officer Paul Williams - Senior Vice Pr
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
04:45pm, Monday, 30'th Oct 2023
GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its conference call to Wednesday, November 8, at 5:00 pm eastern time to discuss the financi
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
06:30am, Thursday, 19'th Oct 2023
GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023, at 5:00 pm eastern time to discuss the financial
Why Is Emergent Biosolutions (EBS) Down 22.6% Since Last Earnings Report?
12:47pm, Thursday, 07'th Sep 2023
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock?
Emergent Biosolutions to make Narcan opioid overdose treatment available without prescription starting in September
06:14am, Wednesday, 30'th Aug 2023
Emergent Biosolutions Inc. EBS, -7.92% said Wednesday its Narcan nasal spray that's an antidote for an opioid overdose will be available without a prescription starting in September. The Gaithersburg,
Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
09:22am, Wednesday, 23'rd Aug 2023
Emergent BioSolutions is facing equity issuance and significant debt covenants in Q1 2024, but at its core, this is a robust pharma supplier to the U.S. government. The underlying value of the busines
Why Emergent BioSolutions Stock Is Tumbling Today
11:42am, Tuesday, 22'nd Aug 2023
Emergent BioSolutions will be replaced on the S&P SmallCap 600 index. The move is a result of the company's market cap plunging since 2020.
